Recreational use of 3,4-methylenedioxypyrovalerone (MDPV) in the early 2000s prompted numerous scientific investigations of its behavioral and neurochemical effects. The purpose of this study was to further characterize the interoceptive stimulus effects of MDPV using a validated invivo drug-detection assay. Male Sprague-Dawley rats were trained to discriminate 0. . Surprisingly, the 5-HT releaser (+ )-fenfluramine fully substituted in half the subjects, but completely suppressed responding in the remaining subjects. 3,4-Methylenedioxymethamphetamine, 4-methylmethcathinone, and (+ )-lysergic acid diethylamide failed to fully substitute for MDPV. These results indicate that the MDPV cue is similar to cues produced by drugs with predominantly dopamine-increasing effects and perhaps serotonin-releasing effects among individual subjects. Given these findings, further research is warranted to directly assess the contributions of dopamine and serotonin receptor isoforms to the discriminative stimulus functions of MDPV. Behavioural Pharmacology 28:394-400 Copyright
Introduction
Recreational use of the synthetic cathinone, 3,4-methylenedioxypyrovalerone (MDPV), has prompted numerous experimental investigations into its neurochemical and behavioral effects. Recent studies using in-vitro receptor-binding techniques revealed that MDPV potently blocks reuptake of dopamine and norepinephrine at the dopamine and norepinephrine transporters, respectively, but produces relatively weaker effects on serotonin uptake at the serotonin transporter (Baumann et al., 2013; Eshleman et al., 2013; Simmler et al., 2013) . In addition, MDPV produces dosedependent and statistically significant increases in extracellular dopamine in the nucleus accumbens of conscious male Sprague-Dawley rats (Baumann et al., 2013; Schindler et al., 2016) . Moreover, these effects are 10-fold more potent than the dopamine-increasing effects of cocaine (Baumann et al., 2013) . Further, the results of the aforementioned studies are consistent with electrophysiological studies demonstrating that MDPV produces outward hyperpolarizing currents in hDAT-expressing Xenopus laevis oocytes (Cameron et al., 2013a (Cameron et al., , 2013b , similar to a nonsubstrate protein receptor blocker. Considered together, these findings indicate that MDPV produces effects similar to cocaine at monoamine transporters, but with comparatively weaker effects at serotonin reuptake transporter.
In addition to the foregoing neurochemical and electrophysiological evidence, preclinical behavioral pharmacology studies indicate MDPV may possess a high abuse potential. Several recent studies have investigated the reinforcing and rewarding effects produced by MDPV in nonhuman models of abuse liability. For example, MDPV maintains self-administration (e.g. Watterson et al., 2012; Aarde et al., 2013 Aarde et al., , 2015 Schindler et al., 2016) , lowers intracranial self-stimulation thresholds (Watterson et al., 2012; Bonano et al., 2014a Bonano et al., , 2014b Kolanos et al., 2015) , and produces conditioned place preference in rats (King et al., 2015a (King et al., , 2015b . On the basis of these preclinical findings, it is clear that MDPV can serve as a positive reinforcer or a rewarding stimulus that may lead to excess use and behavioral dependencies in users.
Relatively fewer studies have characterized MDPV as an antecedent source of control over responding using drug discrimination methods. Presently, only one published study trained animals to discriminate MDPV (Fantegrossi et al., 2013) . In that study, male NIH Swiss mice were trained to discriminate 0.3 mg/kg MDPV from saline under a fixed ratio (FR) 10-10-s time-out schedule of evaporated milk reinforcement. Using a cumulative dosing test procedure, MDPV, 3,4-methylenedioxymethamphetamine (MDMA), and methamphetamine fully substituted for the 0.3 mg/kg MDPV cue. Contrariwise, morphine and a cannabinoid CB 1 and CB 2 receptor agonist, JWH-018, produced minimal partial substitution.
A few studies have assessed MDPV for stimulus substitution in rats trained to discriminate other drugs. For example, Gatch et al. (2013) reported that MDPV dose dependently produced full substitution in Long-Evans rats trained to discriminate 10 mg/kg cocaine or 1 mg/kg methamphetamine from saline. Harvey and Baker (2016) observed full substitution with MDPV in SpragueDawley rats trained to discriminate a drug mixture consisting of 0.5 mg/kg D-amphetamine and 1.5 mg/kg MDMA; however, MDPV produced no more than partial substitution in rats trained to discriminate 1.5 mg/kg MDMA from saline. Finally, Gannon et al. (2016) demonstrated that the (S)(+ )-MDPV isomer fully substituted for 10 mg/kg cocaine more potently than the (R)(− )-MDPV isomer, but not compared with the racemic mixture or cocaine. Together, these findings suggest that MDPV produces interoceptive cues similar to prototypical psychostimulant drugs that increase extracellular dopamine levels.
In light of the foregoing drug discrimination studies, additional investigations are warranted to further evaluate the interoceptive stimulus effects of MDPV in animals trained to discriminate this substance. Although MDPV shares structural similarities to substituted phenethylamines, such as MDMA, amphetamine, and methamphetamine, and comparable pharmacological mechanisms of action to cocaine (Baumann et al., 2013) , knowledge of a drug's chemical structure and mechanisms of action determined in vitro cannot fully predict its interoceptive effects. However, this information is useful for selecting drugs for stimulus substitution for imperfectly understood training drugs (e.g. emerging drugs of abuse). As such, D-amphetamine, (+ )-methamphetamine, MDMA, and (− )-cocaine were selected to assess substitution to MDPV in the present study. Moreover, the synthetic cathinone, 4-methylmethcathinone (4-MMC), was also included as a test compound, given its similar pharmacological effects to MDMA at monoamine transporters measured in vitro and in vivo (e.g. Baumann et al., 2012) . The 5-HT releaser, (+ )-fenfluramine, and the ergoline derivative, (+ )-lysergic acid diethylamide (LSD), were also included in the substitution test series and were predicted to serve as negative controls.
Methods

Subjects
Eight male Sprague-Dawley rats weighing 350-400 g (Charles River Laboratories, Wilmington, Massachusetts, USA) were individually housed in polycarbonate cages with corncob bedding in a temperature-controlled and humidity-controlled colony maintained on a 12/12 h-light/ dark schedule (lights on at 08:00 h). Rats received daily food rations (LabDiet; PMI Nutrition International LLC, Brentwood, Missouri, USA) and were maintained at 85-90% free-feeding weights. Access to water was unrestricted in home cages. All procedures were conducted in accordance with the Guide for the Care and Use of Laboratory Animals (2013) and were approved by the Institutional Animal Care and Use Committee of Western Michigan University.
Apparatus
Eight computer-operated rat operant conditioning chambers (ENV-100; MED Associates, St Albans, Vermont, USA), contained in sound-attenuating cabinets equipped with fans, were used for all training and testing sessions. All chambers were equipped with three retractable levers, a food magazine, and a 10 V house light. Two levers were equidistant from the center lever that was located directly beneath the food magazine along the front wall. Food reinforcers consisted of 45 mg powderless food pellets (Bioserv, Frenchtown, New Jersey, USA). Experimental events were recorded using Med-PC software, version IV (MED Associates).
Training procedures
On the first day of training, all subjects were placed in the operant conditioning chambers for a single 60-min session, with food delivery occurring under a VT 60-s schedule of reinforcement. All subjects consumed all pellets delivered to the food magazine and proceeded to lever-press training.
During lever-press training, each rat was placed in an operant chamber with only the center lever extended. Food deliveries were programmed under an FR schedule of reinforcement. All subjects were required to earn five pellets under a given FR schedule before the FR requirement increased by one. Lever-press training sessions comprised the following five phases in which the FR schedule was gradually incremented: (i) FR 1 to FR 5; (ii) FR 5 to FR 10; (iii) FR 10 to FR 15; (iv) FR 15 to FR 20; and (v) FR 20. These sessions were programmed to engender reliable lever pressing under the terminal FR 20 schedule. If a subject did not display reliable responding under some FR schedule, the response requirement was reduced for remedial training. Each session lasted 30 min or after the delivery of 60 food pellets, whichever occurred first. All subjects proceeded to errorless training after 7-10 lever-press training sessions.
During errorless training sessions, rats were injected (intraperitoneal) with either 0.3 mg/kg MDPV (drug, D) or 0.9% bacteriostatic saline (vehicle, V) and placed into the chamber with only the condition-appropriate lever present (left or right). Four subjects were assigned the left lever for D injections and the right lever for V injections. Conditions were reversed for the remaining four subjects. Lever-press responses were reinforced under an FR 20 schedule of reinforcement and all rats were exposed to six 20-min errorless training sessions in the following order with one session per day: V, V, D, D, V, D. All rats proceeded to discrimination training after the sixth errorless training session.
During discrimination training sessions, rats were injected with either D or V and placed in the chamber with both levers extended. These sessions lasted 20 min and were conducted once per day, 5-6 days per week. D and V injections were implemented in a pseudorandom order, under the restriction that no subject received more than two consecutive D or V training sessions throughout the study. Consistent with errorless training, the D and V lever assignments remained constant for each subject and counterbalanced across subjects. The criteria for discrimination training required each subject to emit 80% or more condition-appropriate responding before the delivery of the first reinforcer and for the remainder of the training session for at least eight of 10 consecutive sessions.
Once a subject met the discrimination training criteria, stimulus substitution tests were commenced. A test session occurred after a subject completed at least one D training session and one V training session in which it met the aforementioned training criteria. If a subject failed to meet the training criteria, training sessions continued until it met the criteria for two consecutive sessions. Doses of substitution test compounds were counterbalanced across subjects in each training group. Substitution tests occurred no more than two times per week. During a stimulus substitution test, subjects were injected with a dose of one of the test compounds, returned to their home cages, and subsequently placed into the experimental chamber after the 15-min injection interval had elapsed. Test sessions were conducted under extinction and ended when a subject completed an FR 20 on either lever or after 20 min elapsed, whichever occurred first. In addition, vehicle (V) substitution tests were included in the MDPV, 4-MMC, D-amphetamine, (+ )-methamphetamine, (− )-cocaine, and MDMA substitution test series. Doses for all substitution test compounds were selected based on previous drug discrimination studies completed in-house that included testing in the same species by the same (intraperitoneally) route of drug administration. 
Data analysis
Acquisition of drug stimulus control was determined by the number of discrimination training sessions required to reach the training criteria. A learning curve was created to display averaged percent MDPV-lever selection values during the first FR as a function of training sessions. Percent MDPV-lever selection was determined by dividing the number of responses on the D lever by the total number of responses emitted up to completion of the first FR 20 on either lever. Response rate was recorded as the number of responses per second. For drug substitution tests, the percent MDPV-lever selection and responses per second were reported as group mean SE in dose-response curves. Full substitution was considered to occur at 80% or more MDPV-lever selection, partial substitution was considered to occur at more than 20% but less than 80% MDPV-lever selection, and 20% or less MDPV-lever selection was considered no substitution. To compare potencies of drugs that produced full substitution, median effective dose values (ED 50 ; with a range set from 0 to 100%) were calculated by fitting linear regression functions to the dose-response curves using a least squares regression analysis. Linear portions of dose-response curves, including not more than a single dose producing less than 20% MDPV-lever selection and not more than a single dose producing more than 80% MDPV-lever selection, were used to compute regression equations. Estimated ED 50 values were then computed for each test compound using the calculated regression equations, and 95% confidence intervals (CIs) were attached to each estimated value. Further, ED 50 values were only computed if, in addition to a test compound producing full substitution, at least four of the eight subjects completed the FR 20 on either lever during a test sessions. For all dose-response curves, the percent substitution value for the V test was determined by calculating the average of all five V substitution tests (see above).
Response rates are presented as the number of responses emitted per second divided by the total test session time. Response rate data associated with each substitution test drug were analyzed by one-way repeated-measures analysis of variance followed by a Dunnett's multiple comparisons test that compared each dose of a test drug to the response rate observed under V. Similar to the percent substitution value for V, the response rate value for V was determined by calculating the average of all response rates obtained during V substitution tests. Statistical significance was identified at P value less than or equal to 0.05. All graphic displays and statistical analyses were conducted using PRISM GraphPad, version 7 software (GraphPad Software, La Jolla, California, USA).
Results
A major goal of this study was to establish MDPV stimulus control over lever-press responding in rats. Acquisition of drug stimulus control was acquired in an average of 35.38 4.77 sessions. Figure 1 displays the learning curve of rats trained to discriminate 0.3 mg/kg MDPV from saline. Each data point represents the mean SE for each percent MDPV-lever selection before the delivery of the first reinforcer under the FR 20 schedule of reinforcement. Note that both D and V sessions are plotted in Fig. 1 as percent MDPV-lever selection. As evident in Fig. 1 , as training sessions progressed, the separation between D-injection values occurring above the 80% dashed line and V-injection values occurring below the 20% dashed line become more evident, reflecting the development of stimulus control by MDPV.
To further characterize the interoceptive stimulus effects of MDPV, stimulus substitution was assessed with a broad range of pharmacological agents. For all substitution tests, individual dose-response curves of drugs with similar pharmacological effects (e.g. dopamine releaser) are grouped into single figure Fig. 3 . 4-MMC dose dependently produced increases in percent MDPV-lever selection and approached full substitution in six of eight subjects (77.26 12.46%). There was a significant main effect of 4-MMC on response rate [F(6, 42) = 15.22, P < 0.001, η 2 = 0.49]: the 3 and 10 mg/kg doses of 4-MMC decreased response rate compared with V. MDMA produced low partial substitution up to the 3 mg/kg (n = 7) dose (26.62 14.52%). There was a significant effect of MDMA on response rate [F(4, 28) = 5.57, P < 0.002, η 2 = 0.25]: the 3 mg/kg dose of MDMA decreased response rate compared with V. (+ )-LSD produced low partial substitution (n = 7) at the 0.1 mg/kg dose (28.80% 15.01), with no significant effect on response rate [F(3, 21) = 2.40, P = 0.10]. Finally, (+ )-fenfluramine produced a low percentage of responses on the MDPV-lever at the three lowest doses tested. However, 3 mg/kg (+ )-fenfluramine produced full substitution in four of the eight subjects (89.88 10.12%) (ED 50 = 1.39 mg/kg; 95% CI = 0.9697-2.385). Responding in the remaining four subjects was completely suppressed by this dose. There was a statistically significant effect of fenfluramine on response rate [F(5, 35) = 6.28, P < 0.001, η 2 = 0.37]: the 0.03 and 3 mg/kg doses of fenfluramine each decreased response rates compared with V. Learning curve of rats trained to discriminate 0.3 mg/kg 3,4-methylenedioxypyrovalerone (MDPV) from saline. Filled circles (•) represent the effect of 0.3 mg/kg MDPV and open circles (○) represent response to vehicle (mean SE). After session 20, the sample size is less than 8 (indicated by number in parentheses) in some training sessions, owing to some subjects having met the discrimination criteria and undergoing substitution tests during those sessions.
Discussion
Discriminative stimulus control by 0.3 mg/kg MDPV was established within an average of ∼ 35 discrimination training sessions in the present study. These results demonstrate that 0.3 mg/kg MDPV can serve as an antecedent source of control over lever-press responding in rats. Only one previous study has demonstrated discriminative stimulus control by MDPV, using male NIH Swiss mice responding under an FR 10-10-s time-out schedule of evaporated milk reinforcement (Fantegrossi et al., 2013) . The number of training sessions required to reach discrimination acquisition criteria was not reported in that study, precluding comparisons between these two studies regarding the time required to establish stimulus control with MDPV. Notably, the number of training sessions required to establish stimulus control with MDPV in the present study was comparable with that observed in previous drug discrimination studies conducted in the same laboratory with structurally similar training drugs. For example, stimulus control was established with 1.5 mg/kg MDMA in an average of 29 training sessions (Harvey and Baker, 2016) , with 10 mg/kg cocaine in an average of 40 sessions (Kueh and Baker, 2007) , and in an average of 16 or 30 sessions with 1 or 0.3 mg/kg D-amphetamine, respectively (Quisenberry et al., 2013) . Thus, it appears that 0.3 mg/kg MDPV produces stimulus control over responding relatively quickly under standard, two-lever discrimination procedures and this occurs at a rate that is comparable with structurally or pharmacologically related substances.
The substituted phenethylamines, methamphetamine and amphetamine, fully substituted for 0.3 mg/kg MDPV; however, the structurally similar entactogen, MDMA, did not. These data are only partially consistent with the findings reported by Fantegrossi et al. (2013) , who reported both MDMA and methamphetamine produced full substitution in mice trained to discriminate 0.3 mg/kg MDPV from saline. Species differences may account for the variable effects of MDMA on MDPVpercent lever selection between the present study and that of Fantegrossi et al. (2013) . However, additional drug discrimination studies directly comparing the species under identical testing procedures would be necessary to evaluate this speculation. Moreover, previous research has demonstrated comparatively greater neurotoxic effects of MDMA on dopaminergic functioning in mice relative to rats, and greater neurotoxic effects of MDMA on serotonin functioning in rats relative to mice (for review, see Easton and Marsden, 2006) . Thus, it is possible that the relative contribution of dopaminergic versus serotonergic actions of MDMA may differentially influence substitution for MDPV in mice and rats.
As noted above, MDMA and 4-MMC failed to fully substitute in 0.3 mg/kg MDPV-trained rats in the present study; however, 4-MMC approached full substitution at the highest dose tested. Although only a single drug discrimination study has been published using MDPV as the training drug (Fantegrossi et al., 2013 ), other studies have tested 4-MMC for substitution in rats trained to discriminate a DA releaser, methamphetamine, or a monoamine transporter blocker, cocaine, from saline. For example, Gatch et al. (2013) trained groups of rats to discriminate 1 mg/kg methamphetamine or 10 mg/kg cocaine from saline and tested 4-MMC for substitution. In that study, 4-MMC equipotently produced full substitution in both training groups. It is noteworthy that Gatch et al. (2013) used a 33-fold higher training dose of cocaine (10 mg/kg) than the MDPV training dose (0.3 mg/kg) used in the present study. Previous research has demonstrated that MDPV is ∼ 10 times more potent than cocaine at producing locomotor activation (e.g. Baumann et al., 2013) . A comparison of the ED 50 values of MDPV (ED 50 = 0.06 mg/kg) and (− )-cocaine (ED 50 = 0.73 mg/kg) obtained in the present study reveals that MDPV is ∼ 12 times more potent than (− )-cocaine at producing the 0.3 mg/kg MDPV cue, a relative potency difference that is somewhat consistent with that reported by Baumann et al. (2013) . In any event, future studies including a higher training dose of MDPV may be necessary for substrates at monoamine transporters, such as MDMA and 4-MMC, to fully substitute in male rats.
The 5-HT releaser (+ )-fenfluramine and the ergoline derivative, (+ )-LSD, were initially included in the present study as negative controls, given the aforementioned research indicating that MDPV produces relatively weak effects at serotonin reuptake transporter (Baumann et al., 2013) . Surprisingly, 3 mg/kg fenfluramine produced full substitution in four of the subjects, whereas responding was completely suppressed in the other four subjects. It is presently unknown whether the discriminative effects Results of substitution tests with doses of (a) 4-methylmethcathinone (4-MMC), (b) 3,4-methylenedioxymethamphetamine (MDMA), (c) (+ )-lysergic acid diethylamide (LSD), and (d) (+ )-fenfluramine in rats trained to discriminate 0.3 mg/kg 3,4-methylenedioxypyrovalerone (MDPV) from saline. Mean SE percent MDPV-lever selection (left vertical axis) and mean SE responses per second (right vertical axis). Rats that did not complete the fixed ratio during a test session were not included in the mean percent drug-lever selection (the number of rats is indicated in parentheses; otherwise the number of rats was equal to 8). For response rate, statistical differences from V are indicated by asterisks (**P < 0.01, ****P < 0.0001).
of MDPV (including downstream effects) are mediated by stimulation of serotonergic mechanisms, although a recent report revealed that the rewarding and locomotorstimulant effects of cocaine (a drug with pharmacological actions similar to MDPV) are attenuated by 5-HT 2C receptor stimulation (Craige and Unterwald, 2013) . Moreover, alterations in serotonergic neurotransmission can modulate the discriminative stimulus effects of cocaine (for review, see Walsh and Cunningham, 1997) . Thus, it is possible that the interoceptive effects of MDPV may involve serotonergic mechanisms. Further drug discrimination research including drugs with selective actions on serotonergic targets is warranted to evaluate this possibility.
Conclusion
MDPV produced discriminative stimulus effects similar to those of some structurally and pharmacologically related compounds, but not others. The current findings provide evidence that drugs that primarily produce increases in extracellular dopamine may also produce similar discriminative cues to those of MDPV. Although, it is worth noting that MDPV also increases extracellular norepinephrine levels, which may contribute to its discriminative stimulus effects. On the basis of these findings, further drug discrimination studies that include NET inhibitors may identify if norepinephrine contributes to the MDPV interoceptive cue.
